The frequency of and associations with hospitalization secondary to lupus flares from the 1000 Faces of Lupus Canadian cohort

Lupus

Volumn 22, Issue 13, 2013, Pages 1341-1348

  Lee, J ^a   Peschken, C A ^b   Muangchan, C ^c,d   Silverman, E ^e   Pineau, C ^f   Smith, C D ^g   Arbillaga, H ^h   Zummer, M ^i,j   Clarke, A ^f   Bernatsky, S ^f   Hudson, M ^f   Hitchon, C ^c,d   Fortin, P R ^k   Pope, J E ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c ST JOSEPH S HEALTH CENTRE   (Canada)

^d MAHIDOL UNIVERSITY   (Thailand)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

^h UNIVERSITY OF CALGARY   (Canada)

ⁱ MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^j UNIVERSITÉ DE MONTRÉAL   (Canada)

^k UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

1000 Faces of Lupus; Canadian Network for Improved Outcomes in SLE (CaNIOS); hospitalizations; SLAM; SLEDAI; Systemic lupus erythematosus (SLE)

Indexed keywords

SM ANTIBODY;

ABORIGINE; ADULT; ARTICLE; CANADA; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE EXACERBATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HOSPITALIZATION; HUMAN; INFLAMMATION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; PRIORITY JOURNAL; PROTEINURIA; PSYCHOSIS; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

1000 FACES OF LUPUS; CANADIAN NETWORK FOR IMPROVED OUTCOMES IN SLE (CANIOS); HOSPITALIZATIONS; SLAM; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS (SLE);

ADULT; CANADA; DISEASE PROGRESSION; FEMALE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84887036371     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313505689     Document Type: Article

References (38)

1. Cervera R. Systemic lupus erythematosus in Europe at the change of the millennium: Lessons from the "Euro-Lupus Project". Autoimm Rev. 2006 ; 5: 180-186
2. Borchers AT, Keen CL, Shoenfeld Y, Gershwin ME. Surviving the butterfly and the wolf: Mortality trends in systemic lupus erythematosus. Autoimmun Rev. 2004 ; 3: 423-453
3. Urowitz MB, Gladman DD, Tom BD, Ibañez D, Farewell VT. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol. 2008 ; 35: 2152-2158
4. Uramoto KM, Michet CJ, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum. 1999 ; 42: 46-50
5. Clarke AE, Esdaile JM, Bloch DA, Lacaille D, Danoff DS, Fries JF. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis Rheum. 1993 ; 36: 1548-1559
6. Zhu TY, Tam LS, Lee V, Lee K, Li EK. The impact of flare on disease costs of patients with systemic lupus erythematosus. Arthritis Rheum. 2009 ; 61: 1159-1167
7. Krishnan E. Hospitalization and mortality of patients with systemic lupus erythematosus. J Rheum. 2006 ; 33: 1770-1774
8. Edwards CJ, Lian TY, Badsha H, The CL, Arden N, Chng HH. Hospitalization of individuals with systemic lupus erythematosus: Characteristics and predictors of outcome. Lupus. 2003 ; 12: 672-676
9. Petri M, Genovese M. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: A prospective study of the Hopkins Lupus Cohort. J Rheumatol. 1992 ; 19: 1559-1565
10. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
11. Statistics Canada. CANSIM. http://www.statcan.gc.ca/pub/75f0002m/ 75f0002m2007004-eng.pdf (accessed May 17, 2012).
12. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989 ; 32: 1107-1118
13. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
14. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for Systemic Lupus Erythematosus. Arthritis Rheum. 1996 ; 39: 363-369
15. Charlson ME, Pompei P, Alex KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987 ; 45: 373-383
16. Thorburn CM, Ward MM. Hospitalizations for coronary artery disease among patients with systemic lupus erythematosus. Arthritis Rheum. 2003 ; 48: 2519-2523
17. Rojas-Serrano J, Cardiel MH. Lupus patients in an emergency unit. Causes of consultation, hospitalization and outcome. A cohort study. Lupus. 2000 ; 9: 601-606
18. Zonana-Nacach A, Yañez P, Jiménez-Balderas FJ, Camargo-Coronel A. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus. Lupus. 2007 ; 16: 997-1000
19. Petty RE, Laxer RM Textbook of Pediatric Rheumatology. Cassidy JT Petty RE Laxer RM Lindsley CB, ed. Philadelphia, PA: Elsevier Saunders ; 2005: 342-391.
20. Tucker LB, Uribe AG, Fernández M, et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: Results of a nested case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus. 2008 ; 17: 314-322
21. Watson L, Leone V, Pilkington C, et al. Juvenile-onset SLE; disease activity, severity and damage - the UK JSLE Cohort Study. Arthritis Rheum. 2012 ; 64: 2356-2365
22. Livingston B, Bonner A, Pope J. Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: A meta-analysis. Lupus. 2011 ; 20: 1345-1355
23. Livingston B, Bonner A, Pope J. Differences in autoantibody profiles and disease activity and damage scores between childhood- and adult-onset systemic lupus erythematosus: A meta-analysis. Semin Arthritis Rheum. 2012 ; 42: 271-280
24. Bertoli AM, Alarcon GS, McGwin G, et al. Systemic lupus erythematosus in a multiethnic U.S. cohort (LUMINA) XXVII: Factors predictive of a decline to low levels of disease activity. Lupus. 2006 ; 15: 13-18
25. Boey ML, Peebles CL, Tsay G, Feng PH, Tan EM. Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus. Ann Rheum Dis. 1988 ; 47: 918-923
26. Ni JD, Yao X, Pan HF, Li XP, Xu JH, Ye DQ. Clinical and serological correlates of anti-SM autoantibodies in Chinese patients with systemic lupus erythematosus: 1,584 cases. Rheumatol Int. 2009 ; 29: 1323-1326
27. Hitchon CA, Peschken CA. Sm antibodies increase risk of death in systemic lupus erythematosus. Lupus. 2007 ; 16: 186-194
28. Janwityanuchit S, Verasertniyom O, Vanichapuntu M, Vatanasuk M. Anti-Sm: Its predictive value in systemic lupus erythematosus. Clin Rheumatol. 1993 ; 12: 350-353
29. Thompson D, Juby A, Davis P. The clinical significance of autoantibodies profiles in patients with systemic lupus erythematosus. Lupus. 1993 ; 2: 15-19
30. Alba P, Bento L, Cuadrado MJ, et al. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis. 2003 ;: 62556-62560
31. Vilá LM, Alarcón GS, McGwin G, et al. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol. 2005 ; 32: 2150-2155
32. Alarcón GS, McGwin G, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups. VII. Predictors of early mortality in the Lumina Cohort. Lumina Study Group. Arthritis Rheum. 2001 ; 45: 191-202
33. Crosslin KL, Wiginton KL. The impact of race and ethnicity on disease severity in systemic lupus erythematosus. Ethn Dis. 2009 ; 19: 301-307
34. Peschken CA, Esdaile JM. Systemic lupus erythematosus in North American Indians: A population based study. J Rheumatol. 2000 ; 27: 1884-1891
35. Anstey NM, Bastian I, Dunckley H, Currie BJ. Systemic lupus erythematosus in Australian aborigines: High prevalence, morbidity and mortality. Aust N Z J Med. 1993 ; 23: 646-661
36. Law G, Pope J, Peschken C. Barriers to healthcare in a multiethnic cohort of systemic lupus erythematosus (SLE) patients: Patient and physician perceptions. Clin Med Arthritis Musculoskeletal Disord. 2009 ; 2: 1-8
37. Peschken CA, Katz SJ, Silverman E, et al. The 1000 Canadian Faces of Lupus: Determinants of disease outcome in a large multiethnic cohort. J Rheumatol. 2009 ; 36: 1200-1208
38. Canadian Institute for Health Information, Discharge Abstract Database: Inpatient Hospitalization: Volumes, Length of Stay and Standardized Rates (Accessed September 2010). http://www.cihi.ca/cihi-ext-portal/internet/en/ applicationfull/types+of+care/hospital+care/cihi021682.